KAINOS MEDICINE, INC. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2,895 KRW | -5.08% |
|
+7.02% | -32.99% |
| 2023 | Kainos Medicine, Inc.(KOSDAQ:A284620) dropped from S&P Global BMI Index | CI |
| 2022 | Kainos Medicine, Inc. announced that it has received KRW 2.00000052 billion in funding from SC United Co., Ltd. | CI |
| Sales 2018 | - | Sales 2019 | - | Capitalization | 58.73M 80.84B |
|---|---|---|---|---|---|
| Net income 2018 | 3M 4.13B | Net income 2019 | 23M 31.66B | EV / Sales 2018 * | - |
| Net cash position 2018 * | - 0 | Net cash position 2019 * | - 0 | EV / Sales 2019 * | - |
| P/E ratio 2018 * |
-
| P/E ratio 2019 * |
-
| Employees | - |
| Yield 2018 * |
-
| Yield 2019 * |
-
| Free-Float | 87.57% |
More Fundamentals
* Assessed data
More news
| 1 day | -5.08% | ||
| 1 week | +7.02% | ||
| Current month | -20.14% | ||
| 1 month | -20.36% | ||
| 3 months | -27.81% | ||
| 6 months | -9.25% | ||
| Current year | -32.99% |
1 week
2 650.00
3 330.00
1 month
2 275.003 730.00
Current year
2 275.004 750.00
1 year
2 275.006 040.00
3 years
1 795.0022 400.00
5 years
1 795.0033 650.00
10 years
1 795.0033 650.00
| Managers | Title | Age | Since |
|---|---|---|---|
Ki-Sub Lee
CEO | Chief Executive Officer | 73 | 07-06-14 |
Jae-Moon Lee
PSD | President | 66 | - |
In-Chul Kim
PRN | Corporate Officer/Principal | 73 | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Ki-Sub Lee
CEO | Chief Executive Officer | 73 | 07-06-14 |
Jae-Moon Lee
PSD | President | 66 | - |
Kainos Medicine Inc is a Korea-based company mainly engaged in the research and development of pharmaceuticals. The Company is engaged in the research and development of degenerative brain disease treatments, antiviral drugs, anticancer drugs and other products. In addition, the Company is engaged in the research and development of Parkinson's disease drugs, AIDS drugs, blood anticancer drugs and other products.
Calendar
2024-05-09
- Q1 2024 Earnings Release (Projected)
| 1st Jan change | Capi. | |
|---|---|---|
| -32.99% | 58.73M | |
| +1.51% | 42.75B | |
| +49.22% | 41.61B | |
| +8.57% | 41.34B | |
| -12.36% | 26.59B | |
| +8.92% | 25.49B | |
| -25.13% | 18.12B | |
| +29.17% | 12.24B | |
| -3.12% | 11.76B | |
| +6.35% | 11B |
- Stock Market
- Equities
- A284620 Stock
